NeoStem CSO Dr. Robert Preti Elected Vice Chairman of the Alliance for Regenerative Medicine

Robert A. Preti, Ph.D. to Take on New Role at Industry Advocacy Organization Effective January 1, 2015NEW YORK, Nov 25, 2014 (GLOBE NEWSWIRE via COMTEX) NeoStem, Inc. (Nasdaq:NBS) announced today that Dr. Robert Preti, the Company s Chief Scientific Officer and President of its subsidiary, Progenitor Cell Therapy ( PCT ), has been elected Vice Chairman of the Alliance for Regenerative Medicine (ARM), an international organization representing the regenerative medicine and advanced therapies community. Dr. Preti will serve in this role effective January 1, 2015. I am honored by this appointment and look forward to a meaningful contribution as an Officer to further develop and implement ARM s strategy for regenerative medicine advocacy during the course of my term, said Dr. Preti, who had previously served as Executive Committee member and co-chair of the Science and Technology Committee at ARM. As Vice Chair, Dr. Preti will be responsible for the support and promotion of ARM s national
http://bit.ly/11Ssl0V